VISKOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Viskase Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$4.05−0.09 (-2.27%)
Close on Oct 19, 2026
- Market cap
- $58.04M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Viskase statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Viskase | Industry median |
|---|---|---|
| Market Cap | $58.04M | $166.30M |
| Enterprise Value | $232.41M | $88.19M |
| PB Ratio | 0.31 | 2.03 |
| P/TBV Ratio | 0.34 | 2.29 |
Income (trailing twelve months)
| Measure | Viskase | Industry median |
|---|---|---|
| Operating Income | -$9.12M | -$21.40M |
| Pretax Income | -$12.66M | -$14.34M |
| Net Income | -$13.65M | -$22.46M |
| EBITDA | -$9.12M | -$16.91M |
Returns
| Measure | Viskase | Industry median |
|---|---|---|
| Return on Equity (ROE) | -14.6% | -53.2% |
| Return on Assets (ROA) | -5.82% | -40.9% |
| Return on Invested Capital (ROIC) | -4.07% | -32.4% |
| Return on Capital Employed (ROCE) | -3.03% | -38.1% |
Balance sheet
| Measure | Viskase | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $7.91M | $61.43M |
| Total Debt | $183.87M | $118.52M |
| Net Cash (Debt) | -$175.95M | $15.35M |
| Net Cash Per Share | -$12.28 | $0.66 |
| Equity (Book Value) | $186.80M | $49.09M |
| Book Value Per Share | $13.03 | $1.37 |
| Tangible Book Value | $171.13M | $23.52M |
| Working Capital | $103.71M | $76.81M |
Financial position
| Measure | Viskase | Industry median |
|---|---|---|
| Current Ratio | 1.84 | 3.34 |
| Quick Ratio | 0.61 | 2.44 |
| Debt / Equity | 0.98 | 0.52 |
Cash flow (trailing twelve months)
| Measure | Viskase | Industry median |
|---|---|---|
| Operating Cash Flow | -$32.90M | -$12.35M |
Efficiency
| Measure | Viskase | Industry median |
|---|---|---|
| Profits Per Employee | -$13.65M | -$703.34K |
| Employee Count | 1 | 74 |
Dividends and yields
| Measure | Viskase | Industry median |
|---|---|---|
| Earnings Yield | -23.5% | -23.3% |
| Dividend Yield | 0.00% | 1.82% |
| Shareholder Yield | 0.00% | 0.00% |
| Dividend Per Share | $0.00 | $0.83 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Viskase | Industry median |
|---|---|---|
| Shares Outstanding | 14,331,600 | 58,127,000 |
| Shares Change (YoY) | 56.4% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
Taxes
| Measure | Viskase | Industry median |
|---|---|---|
| Income Tax | $1.10M | $79.87K |
Scores
| Measure | Viskase | Industry median |
|---|---|---|
| Altman Z-Score | 0.29 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Viskase's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.